GlassScriptPhysician profile
Michael J Manoles
NPI 1578521555
$200,582.35
in general payments reported to CMS, 2019-2025
14 companies · $39K in 2025
The $39K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $19K · 2021: $34K · 2022: $27K · 2023: $28K · 2024: $35K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $101K · Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $101,175.00 |
| Food and Beverage | $684.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $196,634.81 | 2019-2025 | Clinical Trial Product, Watchman Access System, General - Crm_crm |
| Abbott Laboratories | $1,034.31 | 2019-2021 | |
| Merit Medical Systems INC | $802.05 | 2022 | |
| Medtronic, INC. | $613.18 | 2021-2024 | Corevalve Evolut R, Ffrangio |
| Teleflex LLC | $302.24 | 2023-2024 | Guideliner |
| Braemar Manufacturing, LLC | $248.20 | 2019 | |
| Cardiovascular Systems INC. | $180.11 | 2022 | |
| Gentuity, LLC | $175.07 | 2022 | |
| Philips North America LLC | $167.90 | 2020 | |
| Biotronik INC. | $130.13 | 2022 | |
| Edwards Lifesciences Corporation | $100.10 | 2021-2023 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $93.49 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $71.73 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Manoles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.